Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02940509 · ClinicalTrials.gov registry record · Phase 1
Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids
A Phase 1 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02940509 is a Phase 1 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02940509, a Phase 1 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this research proposal is to determine if the intraoperative administrative of Ketamine and Magnesium during laparoscopic gynecologic surgery improves postoperative pain in patients on chronic opioid therapy for management of chronic pelvic pain.
Interventions
- DRUG Placebo
- DRUG Ketamine plus Magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02940509
The ClinicalTrials.gov registry entry for NCT02940509 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02940509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02940509 about?
NCT02940509 is a clinical study titled "Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids". The goal of this research proposal is to determine if the intraoperative administrative of Ketamine and Magnesium during laparoscopic gynecologic surgery improves postoperative pain in patients on chronic opioid therapy for management of chronic pelvic pain.
What is the current status of trial NCT02940509?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2017-07-01. Estimated completion is 2018-02-27.
What interventions are being tested in trial NCT02940509?
The interventions under investigation include: Placebo (DRUG), Ketamine plus Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT02940509?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.